FDA Inspection
Halo Pharmaceutical, Inc. d/b/a Cambrex WhippanyHalo Pharmaceutical, Inc. d/b/a Cambrex Whippany – FDA Inspection, Dec 8, 2025
Record Details
This FDA Inspection record concerns Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, with an inspection on December 8, 2025, issued by the New Jersey District Office, covering animal drugs & feeds.
- Inspection Date
- December 8, 2025
- Product Type
- Animal Drugs & Feeds
View Company Profile
ID · ff5fde2e-4f0e-44b5-9fd6-ece34ceb3753
Inspection Facts
- Inspection number
- 1297650
- FDA center
- Animal Drugs & Feeds
Other FDA inspections of Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
- FDA Inspection 1197680 - 2023-02-17
- FDA Inspection 1116333 - 2019-12-20
- FDA Inspection 1055544 - 2018-05-30
- FDA Inspection 1027562 - 2017-08-24
- FDA Inspection 1008344 - 2017-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.